Bellerophon slides 21% after IPO

Bellerophon Therapeutics shares are down nearly 21% since their $12-per-share debut earlier this month.

Bellerophon Therapeutics (NSDQ:BLPH) shares are down nearly 21% since its IPO 2 weeks ago, when the stock in the New Jersey-based drug-device company opened at $10 per share, down 16.7% right out of the gate.

Bellerophon Therapeutics

News Well, Drug-Device Combinations, Initial Public Offering (IPO), Wall Street Beat

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1AOPn5e